FiercePharma4h
Syndax inks $350M deal with Royalty Pharma for funding to launch 2 new drugs
To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...
bovnews52m
RPRX Unveiled: The Shocking Truth Behind Royalty Pharma plc’s Latest Stock Movements
On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...
TipRanks on MSN10h
Pharma Mar Hits $10 Million Milestone with Janssen
Pharma Mar SA (ES:PHM) has released an update. Pharma Mar S.A. has received a significant payment of $10 million from Janssen ...
Gland Pharma Q2 Results Live: Profit Falls by 15.74% YOY
Gland Pharma Q2 Results Live : Gland Pharma declared their Q2 results on 04 Nov, 2024, reporting a topline increase of 2.36% ...
Gland Pharma shares zoom 13% despite 16% YoY drop in Q2 profit; here's why
The generic injectable-focused company's consolidated net profit declined to Rs 163.5 crore in Q2 FY25 from Rs 194 crore in ...
India's Mankind Pharma tops Q2 profit view on higher demand for chronic drugs
India's Mankind Pharma reported a better-than-expected second-quarter profit on Tuesday, driven by strong demand for its drugs to treat long-term illnesses, such as diabetes and cardiovascular ...
Mankind Pharma Q2 Results: Net profit rises 29% to Rs 659 crore; revenue up 13.6%
Mankind Pharma Q2 Results: Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658 ...
Fortune India3h
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as ...
NJBIZ18h
Silverman secures US Pharma Lab lease for North Brunswick build-to-suit
US Pharma Lab LLC signed a full-building lease with SL Industrial Partners, a member of the Silverman Group, for a build-to ...
Mankind Pharma Q2 net profit rises 30% to Rs 653 crore, beats estimates
Revenue contribution from Mankind Pharma's mainstay chronic illness drugs segment climbed to 35% from 34%, driving total revenue 14% higher ...
Tonix Pharma Partners for Vaccine Clinical Trial
An update from Tonix Pharma ( (TNXP) ) is now available. Tonix Pharmaceuticals has partnered with the Kenya Medical Research Institute to ...
Pharma, healthcare sector mutual funds deliver up to 44% return in 2024. Should you increase allocation?
The mutual fund expert believes that a strategic allocation of 10-20% in the pharma and healthcare funds could benefit ...